Inhibrx Biosciences, Inc.
Total Trades
31
Buys
11
Sells
20
Largest Trade
$1M+
Insiders
7
Institutional Funds
99
Inst. Value
$1M+
Activist Filings
36
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Kayyem Jon Faiz | Director | BUY | $1M+ | 107K | $14.21 | Nov 22, 2024 |
| Vuori Kristiina MD | Director | BUY | $100K–$500K | 7K | $15.00 | Oct 7, 2024 |
| Lappe Mark | CEO | BUY | $500K+ | 40K | $14.92 | Sep 3, 2024 |
| Vuori Kristiina MD | Director | BUY | $50K–$100K | 7K | $14.00 | Sep 3, 2024 |
| MANHARD KIMBERLY | Director | BUY | $100K–$500K | 10K | $13.98 | Aug 30, 2024 |
| FORSYTH DOUGLAS | Director | BUY | $1M+ | 75K | $13.83 | Aug 26, 2024 |
| Lappe Mark | CEO | BUY | $500K+ | 40K | $12.96 | Aug 22, 2024 |
| Kayyem Jon Faiz | Director | BUY | $500K+ | 58K | $17.32 | Jun 7, 2024 |
| Kayyem Jon Faiz | Director | BUY | $1M+ | 287K | $17.18 | Jun 4, 2024 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $1M+ | 300K | $34.30 | May 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 10% Owner | BUY | $1M+ | 512K | $19.35 | Aug 31, 2023 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $500K+ | 40K | $24.21 | Mar 2, 2023 |
| Lappe Mark | CEO | SELL | $1K–$15K | 60 | $25.02 | Mar 1, 2023 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $500K+ | 40K | $24.93 | Feb 3, 2023 |
| Lappe Mark | CEO | SELL | $500K+ | 26K | $25.42 | Jan 24, 2023 |
| Kayyem Jon Faiz | Director | SELL | $100K–$500K | 10K | $25.26 | Jan 23, 2023 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $500K+ | 40K | $23.71 | Jan 4, 2023 |
| Kayyem Jon Faiz | Director | SELL | $100K–$500K | 10K | $27.02 | Dec 22, 2022 |
| Lappe Mark | CEO | SELL | $500K+ | 26K | $25.56 | Dec 20, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $1M+ | 40K | $27.22 | Dec 7, 2022 |
| Kayyem Jon Faiz | Director | SELL | $100K–$500K | 10K | $29.89 | Nov 22, 2022 |
| Lappe Mark | CEO | SELL | $500K+ | 26K | $27.88 | Nov 18, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $1M+ | 40K | $33.51 | Nov 2, 2022 |
| Kayyem Jon Faiz | Director | SELL | $100K–$500K | 10K | $30.13 | Oct 24, 2022 |
| Lappe Mark | CEO | SELL | $500K+ | 26K | $29.59 | Oct 18, 2022 |
| VIKING GLOBAL INVESTORS LP | 10% Owner | BUY | $1M+ | 1.3M | $30.00 | Oct 12, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $1M+ | 40K | $27.82 | Oct 5, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $500K+ | 40K | $14.91 | Sep 7, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $500K+ | 40K | $18.00 | Aug 4, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $500K+ | 40K | $17.17 | Jul 8, 2022 |
| Eckelman Brendan P. | Chief Scientific O… | SELL | $1K–$15K | 400 | $25.04 | Apr 7, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 99 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 1.5M | $1M+ | SH |
| VIKING GLOBAL INVESTORS LP | 1.4M | $1M+ | SH |
| Sanofi | 1.2M | $1M+ | SH |
| HighTower Advisors, LLC | 871K | $1M+ | SH |
| VANGUARD GROUP INC | 556K | $1M+ | SH |
| Sofinnova Investments, Inc. | 455K | $1M+ | SH |
| Capital Research Global Investors | 422K | $1M+ | SH |
| STATE STREET CORP | 375K | $1M+ | SH |
| Caligan Partners LP | 324K | $1M+ | SH |
| PFM Health Sciences, LP | 266K | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 264K | $1M+ | SH |
| Schonfeld Strategic Advisors LLC | 215K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 196K | $1M+ | SH |
| DLD Asset Management, LP | 144K | $1M+ | SH (Call) |
| NORGES BANK | 133K | $1M+ | SH |
| CDC Financial, Inc. | 111K | $1M+ | SH |
| UBS Group AG | 74K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 71K | $1M+ | SH |
| CITIGROUP INC | 56K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 53K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
10.0%
1.5M shares
SC 13G · Feb 11, 2026
7.9%
1.2M shares
SC 13G · Jan 21, 2026
5.3%
768K shares
SC 13G/A · Oct 17, 2025
4.7%
680K shares
The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
SC 13D/A · Feb 26, 2025
3.5%
509K shares
SC 13D/A · Feb 26, 2025
6.4%
925K shares
SC 13G · Feb 4, 2025
5.7%
832K shares
SC 13G · Nov 15, 2024
9.9%
1.5M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Jun 7, 2024
12.3%
1.8M shares
The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
SC 13D · Jun 4, 2024
5.6%
806K shares
SC 13D · Jun 4, 2024
5.3%
761K shares
SC 13G/A · Jun 3, 2024
0.0%
0 shares
SC 13G · May 31, 2024
8.0%
1.2M shares
SC 13G/A · Feb 14, 2024
7.0%
3.3M shares
SC 13G/A · Feb 14, 2024
10.0%
4.7M shares
SC 13G/A · Feb 14, 2024
9.9%
4.8M shares
SC 13G/A · Feb 14, 2024
5.2%
2.5M shares
Eckelman Living Trust Dated February 5, 2014
SC 13G/A · Feb 14, 2024
4.3%
2.0M shares
SC 13G/A · Feb 14, 2024
15.1%
7.2M shares
SC 13G/A · Jan 29, 2024
5.7%
2.7M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
3.5%
0 shares
SC 13G/A · Mar 8, 2023
5.8%
2.5M shares
Eckelman Living Trust Dated February 5, 2014
SC 13G/A · Mar 8, 2023
4.9%
2.2M shares
SC 13G/A · Mar 8, 2023
7.6%
3.3M shares
SC 13G/A · Feb 14, 2023
8.9%
3.9M shares
SC 13G/A · Feb 14, 2023
7.6%
3.3M shares
SC 13G/A · Feb 14, 2023
15.2%
6.6M shares
SC 13G · Feb 3, 2023
5.5%
2.4M shares
SC 13G · Oct 17, 2022
8.2%
3.2M shares
SC 13G · Jul 19, 2022
5.0%
2.0M shares
SC 13G/A · Feb 14, 2022
14.0%
5.3M shares
Deveraux Trust U/A DTD 10/19/2009
SC 13G/A · Feb 11, 2022
5.0%
2.0M shares
SC 13G/A · Feb 11, 2022
8.7%
3.4M shares
Eckelman Living Trust Dated February 5, 2014
SC 13G/A · Feb 11, 2022
6.6%
2.6M shares
SC 13G/A · Feb 11, 2022
6.6%
2.6M shares